Medical University of Graz
Graz, 8043, Austria
Location status: Recruiting
NCT Number: NCT06891131
The investigators will evaluate the implementation of a treatment bundle (Fibrinogen, Plasma and Tranexamic Acid)
Interested in participating?
Request Info18 year and older
All sexes
Observational
Graz, 8043, Austria
Location status: Recruiting
The investigators will perform a prospective observational study of patients in haemorrhagic shock with suspected life threatening bleeding from trauma, treated by the prehospital emergency doctor response team of the Medical University of Graz and the HEMS (Helicopter Emergency Medical Service) of Graz according to their SOPs. Only patients that are being transported to the resuscitation room of the Medical University of Graz after prehospital transfusion will be included.
The SOPs for prehospital transfusion are being implemented for the treatment of patients in extremis because of suspected life-threatening traumatic bleeding in the above-mentioned emergency services, according to the manufacturer's requirements. These transfusion SOPs are already part of the standard of care in the resuscitation room of the Medical University of Graz.
This study seeks to gather information on the benefits and potential harms of this change of prehospital clinical routine.
The treatment bundle will include 2 units of Fibrinogen and Plasma in addition to 10-20 mg/kg Tranexamic Acid
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: prehospital setting
to assess feasibility
Time frame: 30 days
Time frame: 24 hours
Time frame: 2 hours
measured in the emergency department
Contact information is provided by the study sponsor or research team.
Medical University of Graz
Other
Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock: a Prospective Observational Study C-TOP - Coagulation Therapy for Out-of-Hospital Patients
Acronym: C-TOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05449834
Cardiovascular Diseases, Coagulopathy
Newcastle, New South Wales, Australia
View Trial DetailsNCT04561050
Accidental Injuries, Adult
Lausanne, Canton of Vaud, Switzerland
View Trial DetailsNCT00945542
Cardiovascular Diseases, Hematologic Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT06891599
Cardiovascular Diseases, Hematologic Diseases
Stockholm, Sweden
View Trial Details